onCour Pharma, Inc.
2Patents
2Active
2Granted
42Portfolio score
Filing activity: Mar 12, 2018 → Oct 3, 2018
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11045492B2 | Immune-modifying nanoparticles for the treatment of inflammatory diseases | Emerging Cross-Sectional Technologies | 0 | Active |
| US11020424B2 | Modified immune-modulating particles | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.